Atlas Trials

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer

Clinical trial NCT04894643 · RECRUITING

Trial details

NCT number
NCT04894643
Sponsor
EBG MedAustron GmbH
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic CancerProton Therapy
Start date
2020-09-14
Primary completion
2026-12-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.